© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Customized treatments demonstrate good response rates for mantle cell lymphoma and chronic lymphocytic leukemia.
Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.
Imbruvica plus Gazyva is the first chemotherapy-free regimen for chronic lymphocytic leukemia.
The professional wrestler has lived with the cancer since age 22.
Timothy Brown may have company after a man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.
Read books on being diagnosed with cancer and much more.
Researchers believe their greater understanding of leukemia stem cells will lead to more treatment options for people with the blood cancer.
A look back at some of the major news stories we covered this year.
Imbruvica-based treatment may also work better than intensive chemotherapy for younger patients.
The new therapies include immune checkpoint inhibitors; therapeutic vaccines; CAR T-cell therapies; and “conjugate” drugs.
The study focused on children with a form of acute myeloid leukemia (AML), and the findings could also be relevant to other blood disorders.
Women with the chronic condition are 6 percent more likely than men to develop cancer.
New tech enables deep dive into mysterious results, sets stage for future improvements.
Kymriah, a novel CAR-T therapy, helps the immune system recognize and fight cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
